4Tsiara S,Elisaf M,Mikhailidis D,et al.Early vascular benefits of statin therapy.Curr Med Res Opin,2003,19:540-556.
二级参考文献15
1[1]Edelberg J,Pizzo SV.Lipoprotein(α)regulates plasmin generation and inhibition.Chem Phys Lipids,1994,67:363-368.
2[2]Lacoste L,Lam JYT.Comparative effect of pravastatin and imvastatin on platelet-thrombus formation in hypercholesterolemic coronary patients.JACC,1996,27(suppl):413A.
3[3]Davidson M,MeKenney J,Stein E,et al.Comparison of one year efficacy and safety of atorvastain versus lovastatin in primary hypercholesterlemia.Am J Cardiol,1997,79:1475.
4[4]Hunninghake DB,Stein EA,Mellies MJ.Effects of one year of treatment with provastatin,an HMG-CoA reductase inhibitor,on lipoproteins.J Clin Pharmacol,1993,33:574.
5[5]Edwards CJ,Hart DJ,Spector TD.Oral statins andincreased bone-mineral density in postmenopausal womena.Lancet,2000,355:2218-2219.
6[6]Kirsch T,Nickel J,Sebald W.BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-Ⅱ.Embo-J,2000,19:3314-3324.
7[7]Mundy G,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,1999,286:1946-1949.
8[8]Mundy G,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,2000,285:1946-1949.
9[9]Traianedes K,Dallas MR,Garrett IR,et al.5-Lipoxygenase metabolites inhibit bone formation in vitro.Endocrinology,1998,139:3178-3184.
10[10]Chan KA,Andrade SE,Boles M,et al.Inhibitors of hydroxymethylgutarylcoenzyme A reductase and risk of fracture among older women.Lancet,2000,355:2185-2188.
6HOTTA K, FUNAHASHI T, ARITA Y, et al. Plasma concentrations of a novel, adipose-spe- cificprotein, adiponectin, in type 2 diabetic patients [J].Arterioscler Thromb Vasc Biol, 2000, 20:1595 --1599.
7YOKOTA T, ORITANI K, TAKAHASHI I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[J]. Blood, 2000, 96: 1723--1732.
8HASHIMOTO M, AKITA H. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days[J]. Circulation, 2002, 105: E30--E31.
9TSIARA S, ELISAF M. Early vascular benefits of statin therapy[J]. Curr Med Res Opin, 2003, 19: 540--556.
